Founders Financial Securities’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $939K | Buy |
5,060
+54
| +1% | +$10K | 0.07% | 245 |
|
|
2025
Q1 | $963K | Buy |
5,006
+685
| +16% | +$132K | 0.08% | 225 |
|
|
2024
Q4 | $768K | Sell |
4,321
-117
| -3% | -$20.8K | 0.07% | 215 |
|
|
2024
Q3 | $876K | Sell |
4,438
-1,725
| -28% | -$341K | 0.08% | 196 |
|
|
2024
Q2 | $1.06M | Buy |
6,163
+1,599
| +35% | +$274K | 0.1% | 172 |
|
|
2024
Q1 | $831K | Sell |
4,564
-307
| -6% | -$55.9K | 0.09% | 187 |
|
|
2023
Q4 | $755K | Buy |
4,871
+853
| +21% | +$132K | 0.08% | 198 |
|
|
2023
Q3 | $599K | Buy |
4,018
+362
| +10% | +$54K | 0.08% | 193 |
|
|
2023
Q2 | $493K | Buy |
3,656
+247
| +7% | +$33.3K | 0.07% | 215 |
|
|
2023
Q1 | $543K | Sell |
3,409
-131
| -4% | -$20.9K | 0.08% | 193 |
|
|
2022
Q4 | $572K | Sell |
3,540
-357
| -9% | -$57.7K | 0.09% | 185 |
|
|
2022
Q3 | $523K | Buy |
3,897
+324
| +9% | +$43.5K | 0.09% | 174 |
|
|
2022
Q2 | $547K | Sell |
3,573
-27
| -0.8% | -$4.13K | 0.11% | 153 |
|
|
2022
Q1 | $584K | Buy |
3,600
+59
| +2% | +$9.57K | 0.1% | 160 |
|
|
2021
Q4 | $479K | Sell |
3,541
-54
| -2% | -$7.31K | 0.09% | 175 |
|
|
2021
Q3 | $388K | Buy |
3,595
+171
| +5% | +$18.5K | 0.08% | 191 |
|
|
2021
Q2 | $386K | Buy |
3,424
+55
| +2% | +$6.2K | 0.08% | 201 |
|
|
2021
Q1 | $365K | Sell |
3,369
-719
| -18% | -$77.9K | 0.08% | 181 |
|
|
2020
Q4 | $438K | Buy |
4,088
+1,635
| +67% | +$175K | 0.1% | 139 |
|
|
2020
Q3 | $215K | Sell |
2,453
-2,595
| -51% | -$227K | 0.07% | 152 |
|
|
2020
Q2 | $490K | Buy |
+5,048
| New | +$490K | 0.16% | 99 |
|